SAN FRANCISCO, Oct. 23, 2025 /PRNewswire/ -- Alife Health, a health tech company advancing the future of fertility care with artificial intelligence, today announced that Embryo Predict™, its ...
SAN FRANCISCO and LOS ANGELES, March 17, 2025 /PRNewswire/ -- Alife Health (Alife), a leading provider of AI-powered tools to advance the in-vitro fertilization (IVF) process, is excited to expand its ...
SAN FRANCISCO and LOS ANGELES, Nov. 19, 2024 /PRNewswire/ -- Alife Health (Alife), the leading technology company building AI tools to advance in-vitro fertilization (IVF) in the US today, announced a ...
Alife Health’s AI-powered selection tool, Embryo Predict, has received the CE Mark certification in compliance with the European Medical Device Regulation (MDR). The tool is a software platform based ...